Brazier, JE and Yang, Y and Tsuchiya, A (2008): A review of studies mapping (or cross walking) from non-preference based measures of health to generic preference-based measures. Published in: European Journal of Health Economics , Vol. 11, No. 2 (2010): pp. 215-225.
Download (537kB) | Preview
This paper presents a systematic review of current practice in mapping between nonpreference based measures and generic preference-based measures. It reviews the studies identified by a systematic search of the published literature and the grey literature. This review seeks to address the feasibility and overall validity of this approach, the circumstances when it should be considered and to bring together any lessons for future mapping studies.
|Item Type:||MPRA Paper|
|Original Title:||A review of studies mapping (or cross walking) from non-preference based measures of health to generic preference-based measures|
|Keywords:||mapping; cross walking; preference-based measures; QALYs|
|Subjects:||I - Health, Education, and Welfare > I3 - Welfare and Poverty > I31 - General Welfare
I - Health, Education, and Welfare > I1 - Health > I19 - Other
|Depositing User:||Sarah McEvoy|
|Date Deposited:||24. Mar 2011 22:19|
|Last Modified:||14. Feb 2013 10:28|
Ara R, Brazier JE (2007). Deriving an algorithm to convert the 8 mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies when patient level data are not available. Health Economics and Decision Science Discussion Paper, University of Sheffield.
Barton GR, Bankart J, Davis AC, Summerfield QA (2004). Comparing utility scores before and after hearing-aid provision. Appl Health Econ Health Policy 3(2):103-5.
Bansback N, Marra C, Tsuchiya A, Anis A, Guh D, Hammond T, Brazier J (2007 in press). Using the Health Assessment Questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. Arthritis Care Research.
Bartman BA, Rosen MJ, Bradham DD, Weissman J, Hochberg M, Revicki DA (1998) Relationship between health status and utility measures in older claudicants. Quality of Life Research 7:67-73.
Brazier J, Roberts J, Deverill M (2002). The estimation of a preference-based single index measure for health from the SF-36. Journal of Health Economics 21(2):271-92.
Brazier JE, Ratcliffe J, Tsuchiya A, Solomon J (2007). Measuring and valuing health for economic evaluation. Oxford: Oxford University Press.
Brazier J, Kolotkin RL, Crosby RD, Williams GR (2004) Estimating a preference-based single index for the impact of weight on quality of life-Lite (IWQOL-Lite) instrument from the SF-6D. Value in Health 7:484-96.
Brazier J, Roberts J, Tsuchiya A, Busschbach J (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics 13:873-84.
Brennan DS, Spencer AJ (2006). Mapping oral health related quality of life to generic health state values. BMC Health Services Research 6.
Briggs A, Clark T, Wolstenholme J, & Clarke P (2003) Missing... presumed at random: cost-analysis of incomplete data. Health Economics 12:377-92.
Bryan S, Longworth L (2005). Measuring health related quality utility: why the disparity between EQ-5D and SF-6D? The European Journal of Health Economics 6(3):253-60.
Buxton MJ, Lacey LA, Feagan BG, Oliver R (2007). Mapping from Disease-specific measures to utility: an analysis of the relationship between the Inflammatory Bowel Disease Questionnaire and Crohan's Disease Activity Index in Crohn's disease and measures of utility. Value in Health 10:1-7.
Buxton M, Lacey L, Niecko T, Miller D, Townsend R (2005). Mapping from disease specific measures to utility: Algorithms for estimating EQ-5D and SF-6D values from the inflammatory bowel disease questionnaire in patients with Crohn's disease. Value in Health 8:A3-A4.
Chancellor JVM, Coyle D, Drummond MF (1997). Constructing health state preference values from descriptive quality of life outcomes: mission impossible? Quality of Life Research 6:159-68.
Clayson DJ, Briggs AH, Sculpher M, De Hert M (2004). Mapping utility scores from the EQ-5D and SF-6D onto the schizophrenia quality of life scale. Value in Health 7:277.
Coast J (1992). Reprocessing data to form QALYs. British Medical Journal 305:87-90.
Dixon S, McEwan P, Currie CJ (2003). Estimating the health utility of treatment in adults with growth hormone deficiency. Journal of Outcome Research 7:1-12.
Dobrez D, Cella D, Pickard AS, Lai JS, Nickolov A (2007 in press) Estimating of patient preference-based utility weights from the functional assessment of cancer therapy - general. Value in Health.
Edlin R, Tsuchiya A, Brazier J (2002). Mapping the Nepean Dyspepsia Index and patient self-assessed (clinical) data to SF-6D preference weights. Unpublished manuscript.
Edlin R, Tsuchiya A, Brazier J (2002). Mapping the Minnesota Living with Heart Failure Questionnaire to the EQ-5D index. Unpublished manuscript.
Epstein D, Manca A (2003). A comparison of the SF-6D and EQ-5D: How does the choice of health outcome measure matter? Health Economists Study Group Meeting (HESG), July 2003.
Feeny D, Wu L, Eng K (2004). Comparing short form 6D, standard gamble, and health utilities index Mark 2 and Mark 3 utility scores: Results from total hip arthroplasty patients. Quality of Life Research 13:1659-70.
Franks P, Lubetkin EI, Gold MR, Tancredi DJ (2003). Mapping the SF-12 to preference-based instruments. Medical Care 41:1277-83.
Franks P, Lubetkin EI, Gold MR, Tancredi DJ, Jia H (2004). Mapping the SF-12 to the EuroQol EQ-5D Index in a national US sample. Medical Decision Making 24:247-54.
Fryback DG, Lawrence WF, Martin PA, Klein R, Klein BEK (1997). Predicting quality of well-being scores from the SF-36: Results from the Beaver Dam Health Outcomes Study. Medical Decision Making 17:1-9.
Gray A, Clarke P, Rivero-Arias O (2004). Estimating the association between SF-36 responses and EQ-5D utility values by direct mapping. Health Economists Study Group Meeting (HESG), January 2004, Paris.
Gray A, Rivero-Arias O, Clarke PM (2006). Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Medical Decision Making 26:18-29.
Grootendorst P, Marshall D, Pericak D, Bellamy N, Feeny D, & Torrance GW (2007). A model to estimate Health Utilities Index Mark 3 Utility scores form WOMAC Index scores in the patients with Osteoarthritis of the knee. The Journal of Rheumatology 34:534-42.
Kaambwa B, Bryan S, Barton P, Parker H, Martin G (2006). Relationship between the EuroQol-5d and Barthel Index - examining the use of proxy outcome measures for older people. Health Economists Studying Group Meeting (HESG), July 2006, York.
Lauridsen J, Christiansen T, Hakkinen U (2004). Measuring inequality in self-reported health - discussion of a recently suggested approach using Finnish data. Health Economics 13:725-32.
Lawrence WF, Fleishman JA (2004). Predicting EuroQoL EQ-5D preference scores from the SF-12 health survey in a nationally representative sample. Medical Decision Making 24:160-9.
Longo M, Cohen D, Hood K, Robling M (2000). Deriving an "enhanced" EuroQol from SF-36. Health Economists Study Group Meeting (HESG), July 2000, Nottingham.
Longworth L, Buxton MJ, Sculpher M, Smith AH (2005). Estimating utility data from clinical indicators for patients with stable angina. European Journal of Health Economics 6:347-53.
Lorgelly PK (2001). Mapping SF-36 to utilities: How can it be done? Health Economists Study Group Meeting (HESG), City University, London.
Marra CA, Woolcott JC, Kopec JA, Shojania KI, Offer R, Brazier JE, Esdaile JM, Anis AH (2005). A comparison of generic, indirect utility measures (the HU12, HU13, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science & Medicine 60:1571-82.
Mujica-Mota R, Bagust A, Haycox A, Dhawan R, Dubois D (2004). Mapping health-related quality of life (HRQOL) measurements into generic utility measures (EQ- 5D): A case study with bortezomib (VELCADE). Value in Health 7:693.
Nichol MB, Sengupta N, Globe DR (2001). Evaluating quality-adjusted life years: estimation of the Health Utility Index (HUI2) from the SF-36. Medical Decision Making 21:105-12.
O'Brien BJ, Spath M, Blackhouse G, Severens JL, Dorian P, Brazier J (2003). A view from the bridge: Agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Economics 12:975-981.
Revicki DA, Leidy NK, Brennan-Diemer F, Sorenson S, Togias A (1998). Integrating patients’ preferences into health outcomes assessment: the multi-attribute asthma symptom utility index. Chest 114(4):998-1007.
Richard J, Hall J, Salkeld G (1996). The measurement of utility in multiphase health states. International Journal of Health Technology Assessment in Health Care 12:151-162.
Roberts J, Brazier J, Tsuchiya A (2005). Mapping the overactive bladder questionnaire to SF6D indices stage 2: Final results. Unpublished manuscript
Sengupta N, Nichol MB, Wu J, Globe D (2004). Mapping the SF-12 to the HUI3 and VAS in a managed care population. Medical Care 42:927-37.
Sullivan PW, Ghushchyan V (2006). Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample. Medical Decision Making 26:401-9.
Tsuchiya A, Brazier J, McColl E, Parkin D (2002). Deriving preference-based single indices from non-preference based condition specific instruments: converting AQLQ into EQ-5D indices. HEDS discussion paper.
Tsuchiya A (2006). The estimation of a preference-based single index for the IBS-QoL. Unpublished manuscript.
van Doorslaer E, Jones AM (2003). Inequalities in self-reported health: validation of a new approach to measurement. Journal of Health Economics 22:61-87.
Walters S, Brazier JE (2005). Comparison of the minimally important difference for two health state measures: EQ-5D and SF-6D. Quality in Life Research 14:1523-32.
Wu AW, Huang IC, Gifford AL, Spritzer KL, Bozzette SA, Hays RD (2005). Creating a crosswalk to estimate AIDS clinical trials group quality of life scores in a nationally representative sample of persons in care for HIV in the United States. HIV Clinical Trials 6:147-57.
Wu E, Mulani P, Farrell MH, Sleep D (2006). Mapping Fact-P and Eortc Qlq-C30 to the EQ-5D health utility in metastasis hormone-refractory prostate cancer patients. Value in Health 9:A114.
Yang Y, Tsuchiya A, Brazier J, Young Y (2006). Deriving a preference-based measure for health from the AQLQ. Health Economists Study Group Meeting (HESG), City University, January 2006.